Ophidion partners with Neuronasal for CNS drug delivery
They will co-develop therapies for Parkinson’s disease, obesity, and diabetes using a novel delivery platform.
See the latest news and media coverage for Ophidion. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biopharmaceutical company developing noninvasive CNS treatments
ophidion.comLast updated
They will co-develop therapies for Parkinson’s disease, obesity, and diabetes using a novel delivery platform.
Ophidion, Inc. and Neuronasal, Inc. Announce Strategic Collaborations to Tackle Parkinson’s Disease, Obesity, and Diabetes via Novel CNS Delivery Platform Ophidion, Inc., a biotechnology company...
Track Ophidion and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Ophidion and other trending companies.